NO20006334L - Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav - Google Patents

Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav

Info

Publication number
NO20006334L
NO20006334L NO20006334A NO20006334A NO20006334L NO 20006334 L NO20006334 L NO 20006334L NO 20006334 A NO20006334 A NO 20006334A NO 20006334 A NO20006334 A NO 20006334A NO 20006334 L NO20006334 L NO 20006334L
Authority
NO
Norway
Prior art keywords
hepatitis
preparation
treatment
pharmaceutical formulation
viral liver
Prior art date
Application number
NO20006334A
Other languages
English (en)
Other versions
NO20006334D0 (no
Inventor
Sadras Panchatchar Thyagarajan
Original Assignee
Univ Madras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Madras filed Critical Univ Madras
Publication of NO20006334D0 publication Critical patent/NO20006334D0/no
Publication of NO20006334L publication Critical patent/NO20006334L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20006334A 1999-04-12 2000-12-12 Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav NO20006334L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN405MA1999 1999-04-12
PCT/IN2000/000046 WO2000061161A2 (en) 1999-04-12 2000-04-10 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation

Publications (2)

Publication Number Publication Date
NO20006334D0 NO20006334D0 (no) 2000-12-12
NO20006334L true NO20006334L (no) 2001-02-12

Family

ID=11095076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006334A NO20006334L (no) 1999-04-12 2000-12-12 Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav

Country Status (9)

Country Link
US (1) US6589570B1 (no)
EP (1) EP1091748A2 (no)
JP (1) JP2002541204A (no)
AU (2) AU5425400A (no)
CA (1) CA2334754A1 (no)
GB (1) GB2355932B (no)
MX (1) MXPA00012330A (no)
NO (1) NO20006334L (no)
WO (2) WO2000061161A2 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919585A1 (de) 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen
US20030129251A1 (en) 2000-03-10 2003-07-10 Gary Van Nest Biodegradable immunomodulatory formulations and methods for use thereof
US7129222B2 (en) 2000-03-10 2006-10-31 Dynavax Technologies Corporation Immunomodulatory formulations and methods for use thereof
DE10030139A1 (de) * 2000-06-20 2002-01-10 Cmi Ag Verwendung von Phyllanthusbesandteilen zur Behandlung oder Prophylaxe von Infekten durch Flaviviridae
DE10120627A1 (de) * 2001-04-26 2002-10-31 Cmi Ag Verwendung von Phyllanthusbestandteilen zur Behandlung oder Prophylaxe von Infekten durch Hepatitis B-Viren
EP1420829A4 (en) 2001-08-07 2006-05-17 Dynavax Tech Corp IMMUNOMODULATING COMPOSITIONS, FORMULATIONS AND METHOD FOR THEIR USE
ATE544453T1 (de) * 2002-07-15 2012-02-15 Gilead Sciences Inc Kombinationstherapien mit l-fmau zur behandlung von hepatitis-b-virus-infektionen
NZ541009A (en) * 2003-01-13 2007-09-28 Dynogen Pharmaceuticals Inc Method of treating nausea, vomiting, retching or any combination thereof
AU2004227945B2 (en) * 2003-04-04 2006-10-26 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
US7772271B2 (en) * 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) * 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) * 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
BRPI0511834A (pt) * 2004-07-14 2008-01-08 Ptc Therapeutics Inc métodos por tratar hepatite c
WO2006019832A1 (en) * 2004-07-22 2006-02-23 Ptc Therapeutics, Inc. Thienopyridines for treating hepatitis c
US20060110479A1 (en) * 2004-11-24 2006-05-25 Mitra Shankar K Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
ATE521359T1 (de) 2005-01-25 2011-09-15 Neumed Inc Zusammensetzung enthaltend ein extrakt eines roharzneistoffkomplexes mit neuroprotektiver aktivität zur vorbeugung und behandlung von schlaganfall
EP2116253A1 (en) * 2008-05-07 2009-11-11 Phytrix JV, LLC Novel phyllanthus extract
CH707029B1 (de) 2011-10-21 2015-03-13 Abbvie Inc Verfahren zur Behandlung von HCV, umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin, aber nicht Interferon.
AU2013201532B2 (en) 2011-10-21 2014-10-02 Abbvie Ireland Unlimited Company Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69718156T2 (de) 1997-04-21 2003-11-06 Dabur Res Foundation Sahibabad Polypflanzliche pharmazeutische Zusammensetzungen geeignet in der Behandlung der Hepatitis E und Hepatitis B Virus-Infektion zusammenhängenden Zustände
WO2000056347A1 (en) * 1999-03-24 2000-09-28 Southern Petrochemical Industries Corporation Limited An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof

Also Published As

Publication number Publication date
US6589570B1 (en) 2003-07-08
GB2355932A (en) 2001-05-09
WO2000061161A3 (en) 2001-02-08
GB0029936D0 (en) 2001-01-24
WO2000061160A2 (en) 2000-10-19
WO2000061161A2 (en) 2000-10-19
MXPA00012330A (es) 2004-12-03
JP2002541204A (ja) 2002-12-03
WO2000061160A3 (en) 2001-01-25
EP1091748A2 (en) 2001-04-18
GB2355932B (en) 2004-01-07
NO20006334D0 (no) 2000-12-12
AU5425400A (en) 2000-11-14
CA2334754A1 (en) 2000-10-19
AU4309500A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
NO20006334L (no) Farmasöytisk formulering til behandling av hepatitt samt andre virale leverinfeksjoner samt fremgangsmåte ved fremstilling derav
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
EE05442B1 (et) V„ikeses annuses entekaviiri sisaldav ravimkoostis B-hepatiidi viirusinfektsiooni raviks ning meetod selle valmistamiseks
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
IL215891A (en) Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections
DK2050445T4 (da) Farmaceutisk sammensætning af phenofibrat med forøget biotilgængelighed samt fremgangsmåde til dens fremstilling
NO20053920D0 (no) Preparat for og behandling av demyelineringssykdommer og paralyse ved administrering av remyelineringsmidler.
PL344223A1 (en) Compositions for the treatment of hiv and other viral infections
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
PT97749A (pt) Processo para a preparacao de composicoes farmaceuticas contendo dsarn apropriadas para o diagnostico e o tratamento de hepatite viral
NO20002174D0 (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20014672D0 (no) Fremgangsmåte ved fremstilling av trisykliske aminoalkoholderivater
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
NO20041855L (no) Fremgangsmate for behandling av hepatitt C-virusinfeksjon ved behandling av feilpasienter
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
NO991164D0 (no) Farmas°ytisk preparat for behandling av virussykdommer
NO20021066D0 (no) Fremgangsmåte ved fremstilling av tricykliske aminoalkoholderivater
DK1212336T3 (da) Fremgangsmåde til fremstilling af sfæriske agglomerater af telithromycin og deres anvendelse ved fremstilling af farmaceutiske former
NO20012518D0 (no) Fremgangsmåte ved fremstilling av legemidler i fast administrasjonsform
NO20032769L (no) Kombinasjonsmetode for behandling av virale infeksjoner
NO996467L (no) FremgangsmÕte for fremstilling av tiazofurin og andre C- nukleosider
NO20041685L (no) Fremgangsmate for behandling av hepatitt C-virusinfeksjon hos pasienter med manglende behandlingsrespons
NO20020073D0 (no) Fremgangsmåte ved fremstilling av trisykliske aminoalkoholderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application